Abstract:The hexameric purine nucleoside phosphorylase from Bacillus subtilis (BsPNP233) displays great potential to produce nucleoside analogues in industry and can be exploited in the development of new anti-tumor gene therapies. In order to provide structural basis for enzyme and substrates rational optimization, aiming at those applications, the present work shows a thorough and detailed structural description of the binding mode of substrates and nucleoside analogues to the active site of the hexameric BsPNP233. Here we report the crystal structure of BsPNP233 in the apo form and in complex with 11 ligands, including clinically relevant compounds. The crystal structure of six ligands (adenine, 2'deoxyguanosine, aciclovir, ganciclovir, 8-bromoguanosine, 6-chloroguanosine) in complex with a hexameric PNP are presented for the first time. Our data showed that free bases adopt alternative conformations in the BsPNP233 active site and indicated that binding of the co-substrate (2'deoxy)ribose 1-phosphate might contribute for stabilizing the bases in a favorable orientation for catalysis. The BsPNP233-adenosine complex revealed that a hydrogen bond between the 5' hydroxyl group of adenosine and Arg(43*) side chain contributes for the ribosyl radical to adopt an unusual C3'-endo conformation. The structures with 6-chloroguanosine and 8-bromoguanosine pointed out that the Cl(6) and Br(8) substrate modifications seem to be detrimental for catalysis and can be explored in the design of inhibitors for hexameric PNPs from pathogens. Our data also corroborated the competitive inhibition mechanism of hexameric PNPs by tubercidin and suggested that the acyclic nucleoside ganciclovir is a better inhibitor for hexameric PNPs than aciclovir. Furthermore, comparative structural analyses indicated that the replacement of Ser(90) by a threonine in the B. cereus hexameric adenosine phosphorylase (Thr(91)) is responsible for the lack of negative cooperativity of phosphate binding in this enzyme.

Synergy between anions and farnesyldiphosphate competitive inhibitors of farnesyl:protein transferase

Phosphinyl acid-based bisubstrate analog inhibitors of Ras farnesyl protein transferase.

Computational studies of the farnesyltransferase ternary complex part I: substrate binding.

Probing the Interaction Induced Conformation Transitions in Acid Phosphatase with Cobalt Ferrite Nanoparticles: Relation to Inhibition and Bio-Activity of Chlorella Vulgaris Acid Phosphatase.

Lipophilic bisphosphonates as dual farnesyl/geranylgeranyl diphosphate synthase inhibitors: an X-ray and NMR investigation.

Enthalpy Versus Entropy-Driven Binding of Bisphosphonates to Farnesyl Diphosphate Synthase

Synthesis and Enzymatic Studies of Bisubstrate Analogues for Farnesyl Diphosphate Synthase

Catalytic Asymmetry in Homodimeric H+-Pumping Membrane Pyrophosphatase Demonstrated by Non-Hydrolyzable Pyrophosphate Analogs

Insights into phosphate cooperativity and influence of substrate modifications on binding and catalysis of hexameric purine nucleoside phosphorylases

On the potential pharmacophore for the structure-based inhibitor design against phosphatases

Differential prenyl pyrophosphate binding to mammalian protein geranylgeranyltransferase-I and protein farnesyltransferase and its consequence on the specificity of protein prenylation

Design, Synthesis, and Biological Evaluation of 2-Substituted Ethenesulfonic Acid Ester Derivatives As Selective PTP1B Inhibitors.

Conformational dynamics and asymmetry in multimodal inhibition of membrane-bound pyrophosphatases

Structural insights into the potency and selectivity of covalent pan-FGFR inhibitors

Structural Basis for Inhibition of the Protein Tyrosine Phosphatase 1B by Phosphotyrosine Peptide Mimetics.

Guanosine thiophosphate derivatives as substrate analogues for phosphoenolpyruvate carboxykinase

Inhibition of the fungal fatty acid synthase type I multienzyme complex

Inhibition of human mevalonate kinase by allosteric inhibitors of farnesyl pyrophosphate synthase

Structure and inhibition mechanisms of essential transporter efflux protein A

Y-shaped Bis-Arylethenesulfonic Acid Esters: Potential Potent and Membrane Permeable Protein Tyrosine Phosphatase 1B Inhibitors.

Inhibition of geranylgeranyl diphosphate synthase by bisphosphonates: a crystallographic and computational investigation.